Slipped Upper Femoral Epiphysis

Slipped upper femoral epiphysis is a condition that primarily affects boys aged 10 to 15. It occurs when the upper femoral epiphysis slips in a posterior inferior direction with respect to the femur. The exact cause of this condition is unclear, but it has been suggested that hormonal or calcification abnormalities may play a role. Obese children with delayed secondary sexual development or tall thin boys are particularly susceptible.

Symptoms of slipped upper femoral epiphysis include rest pain, limp, pain on movement, reduced range of abduction and internal rotation, and an externally rotated and shortened affected leg. It is important to note that musculoskeletal disease doesn’t typically present with a shortened leg.

Other conditions that may be mistaken for slipped upper femoral epiphysis include Perthes’ disease, Osgood-Schlatter syndrome, and chondromalacia patellae. Perthes’ disease is avascular necrosis of the femoral head in childhood, while Osgood-Schlatter syndrome is an overuse syndrome associated with physical exertion before skeletal maturity. Chondromalacia patellae is softening of the articular cartilage of the patella usually caused by indirect trauma.

Autism is characterized by a triad of symptoms including communication impairment, impairment of social relationships, and ritualistic behavior. In this case, the child’s lack of interaction in class represents communication impairment, spending much time alone represents impairment of social relationships, and difficulty changing routine represents ritualistic behavior.

It is important to note that the child’s behavior doesn’t meet the criteria for conduct disorder, which is characterized by repetitive and persistent behavior that violates the basic rights of others or major age-appropriate norms.

While depression and social anxiety may coexist with autism, they would not fully account for the child’s ritualistic behavior and are therefore not the most likely diagnoses.

Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects social interaction, communication, and behavior. It can be diagnosed in early childhood or later in life and is more common in boys than girls. Around 50% of children with ASD also have an intellectual disability. Symptoms can range from subtle difficulties in understanding and social function to severe disabilities. While there is no cure for ASD, early diagnosis and intensive educational and behavioral management can improve outcomes. Treatment involves a comprehensive approach that includes non-pharmacological therapies such as applied behavioral analysis, structured teaching methods, and family counseling. Pharmacological interventions may also be used to reduce symptoms like repetitive behavior, anxiety, and aggression. The goal of treatment is to increase functional independence and quality of life while decreasing disability and comorbidity.

Management of Burn Injuries

Burn injuries can cause thermal damage and inflammation, which can be reduced by cooling the affected area with water at 15oC. However, ice-cold water should be avoided as it can cause vasospasm and further ischaemia. Sensation and capillary refill should be assessed at initial presentation, as full thickness burns are insensitive. Silver sulfadiazine has not been proven to prevent infection. Epidermal burns are characterized by erythema, while larger or awkwardly positioned blisters should be aspirated under aseptic technique to prevent bursting and infection. De-roofing blisters should not be routinely done.

Myasthenia gravis is a condition caused by autoantibodies attacking acetylcholine receptors, resulting in symptoms such as double vision, drooping eyelids, and muscle weakness. It is important to review medication use as certain drugs can worsen symptoms. Testing for anti-acetylcholine receptor antibodies is the first step in diagnosis. Thymoma should be ruled out in newly diagnosed patients. Treatment typically involves oral pyridostigmine and, if necessary, surgery for thymoma. Immunomodulatory agents may be used as the disease progresses.

Motor neurone disease, specifically amyotrophic lateral sclerosis, is characterized by the degeneration of upper and lower motor neurones, leading to progressive muscle weakness without sensory symptoms.

Multiple sclerosis often presents with a variety of neurological symptoms and signs, including motor, sensory, and autonomic issues. Diagnosis requires objective evidence of dissemination in time and space of typical lesions and the exclusion of other possible explanations.

Myalgic encephalomyelitis, also known as chronic fatigue syndrome, causes long-term fatigue and other symptoms such as cognitive difficulties, sleep disturbance, and muscle and joint pains.

Polymyalgia rheumatica is an inflammatory condition with an unknown cause that presents with severe pain and stiffness in the shoulder, neck, and pelvic girdle.

Conditions that can present with extensor plantars and absent ankle jerk, along with mixed upper and lower motor neuron signs, include motor neuron disease, subacute combined degeneration of the cord, and syringomyelia. Other possible conditions to consider are diabetic neuropathy and myasthenia gravis.

Absent Ankle Jerks and Extensor Plantars: Causes and Implications

When a patient presents with absent ankle jerks and extensor plantars, it is typically indicative of a lesion that affects both the upper and lower motor neurons. This combination of signs can be caused by a variety of conditions, including subacute combined degeneration of the cord, motor neuron disease, Friedreich’s ataxia, syringomyelia, taboparesis (syphilis), and conus medullaris lesion.

The absence of ankle jerks suggests a lower motor neuron lesion, while the presence of extensor plantars indicates an upper motor neuron lesion. This combination of signs can help clinicians narrow down the potential causes of the patient’s symptoms and develop an appropriate treatment plan.

It is important to note that absent ankle jerks and extensor plantars are not always present in the same patient, and their presence or absence can vary depending on the underlying condition. Therefore, a thorough evaluation and diagnostic workup are necessary to accurately diagnose and treat the patient.

Updated Guidance for Assessing Patients with TIA

Some healthcare professionals may still be using the old ABCD2 scoring system for assessing patients with a transient ischemic attack (TIA). However, updated guidance advises that if a patient has had a TIA within the last week, they should be given 300 mg aspirin immediately and urgently assessed by a specialist stroke physician within 24 hours. Exceptions include patients with bleeding disorders or those taking anticoagulants, in which case immediate admission for urgent assessment and imaging is necessary. Patients taking low-dose aspirin regularly should continue their current dose until reviewed by a specialist, while those for whom aspirin is contraindicated should have their management discussed urgently with the specialist team.

To aid in rapid assessment, the Face Arm Speech Test (FAST test) can be used. This test is positive if the patient exhibits new facial weakness (such as drooping of the mouth or eye), arm weakness, or speech difficulty (such as slurring or difficulty in finding names for commonplace objects). Proper assessment and management of patients with TIA can help prevent future strokes and improve patient outcomes.

Male adults are the most commonly affected by nasal polyps.

Understanding Nasal Polyps

Nasal polyps are a relatively uncommon condition affecting around 1% of adults in the UK. They are more commonly seen in men and are not typically found in children or the elderly. There are several associations with nasal polyps, including asthma (particularly late-onset asthma), aspirin sensitivity, infective sinusitis, cystic fibrosis, Kartagener’s syndrome, and Churg-Strauss syndrome. When asthma, aspirin sensitivity, and nasal polyposis occur together, it is known as Samter’s triad.

The most common features of nasal polyps include nasal obstruction, rhinorrhoea, sneezing, and a poor sense of taste and smell. However, if a patient experiences unilateral symptoms or bleeding, further investigation is always necessary.

If a patient is suspected of having nasal polyps, they should be referred to an ear, nose, and throat (ENT) specialist for a full examination. Treatment typically involves the use of topical corticosteroids, which can shrink polyp size in around 80% of patients. With proper management, most patients with nasal polyps can experience relief from their symptoms.

Assessment and Severity of Acute Asthma

The British Thoracic Society provides clear guidance on the assessment and management of acute asthma, which is often tested in exams. Indicators of acute severe asthma include a peak expiratory flow rate of 33-50% of the patient’s best or predicted rate, a respiratory rate of 25 or greater, a heart rate of 110/min or greater, and the inability to complete sentences in one breath. Oxygen therapy should aim to maintain SpO2 at 94-98%. Increasing symptoms is not a marker of an acute severe attack, but rather denotes a moderate asthma exacerbation. There is no fixed numerical peak flow rate for all patients, as it depends on their personal best or predicted reading. If their actual peak flow is 33-50% of this figure, then it is a marker of an acute severe attack. In the case of a peak flow of 250 L/min, which is considerably reduced from the patient’s usual best of 600 L/min, this is the only indicator of an acute severe attack. If any of these features persist after initial treatment, the patient should be admitted.

Refeeding Syndrome in Malnourished Patients

Refeeding malnourished patients through enteral feeding requires careful monitoring of electrolytes and minerals. This is because refeeding can trigger a significant anabolic response that affects the levels of electrolytes and minerals essential to cellular function. Unfortunately, refeeding syndrome is often under-recognized and under-diagnosed. The metabolic changes that occur during refeeding can lead to marked hypophosphatemia and shifts in potassium, magnesium, glucose, and thiamine levels.

Refeeding syndrome is primarily caused by hypophosphatemia and can result in severe cardiorespiratory failure, edema, confusion, convulsions, coma, and even death. Therefore, it is crucial to closely monitor patients undergoing refeeding to prevent and manage refeeding syndrome.

Hypertension can be a possible side effect of taking leflunomide.

Leflunomide: A DMARD for Rheumatoid Arthritis

Leflunomide is a type of disease modifying anti-rheumatic drug (DMARD) that is commonly used to manage rheumatoid arthritis. It is important to note that this medication has a very long half-life, which means that its teratogenic potential should be taken into consideration. As such, it is contraindicated in pregnant women, and effective contraception is essential during treatment and for at least two years after treatment in women, and at least three months after treatment in men. Caution should also be exercised in patients with pre-existing lung and liver disease.

Like any medication, leflunomide can cause adverse effects. Some of the most common side effects include gastrointestinal issues such as diarrhea, hypertension, weight loss or anorexia, peripheral neuropathy, myelosuppression, and pneumonitis. To monitor for any potential complications, patients taking leflunomide should have their full blood count (FBC), liver function tests (LFT), and blood pressure checked regularly.

If a patient needs to stop taking leflunomide, it is important to note that the medication has a very long wash-out period of up to a year. To help speed up the process, co-administration of cholestyramine may be necessary. Overall, leflunomide can be an effective treatment option for rheumatoid arthritis, but it is important to carefully consider its potential risks and benefits before starting treatment.

After experiencing a first unprovoked or isolated seizure with normal brain imaging and EEG, patients are not allowed to drive for a period of 6 months. It is their responsibility to inform the DVLA and they may reapply for a license after the 6-month period if no further seizures occur. The incorrect options include stopping driving for one year and informing the DVLA, stopping driving until established on anti-epileptic medication, and stopping driving for 6 months and informing the DVLA only in the event of any further seizures.

The DVLA has guidelines for individuals with neurological disorders who wish to drive cars or motorcycles. However, the rules for drivers of heavy goods vehicles are much stricter. For individuals with epilepsy or seizures, they must not drive and must inform the DVLA. If an individual has had a first unprovoked or isolated seizure, they must take six months off driving if there are no relevant structural abnormalities on brain imaging and no definite epileptiform activity on EEG. If these conditions are not met, the time off driving is increased to 12 months. Individuals with established epilepsy or those with multiple unprovoked seizures may qualify for a driving license if they have been free from any seizure for 12 months. If there have been no seizures for five years (with medication if necessary), a ’til 70 license is usually restored. Individuals should not drive while anti-epilepsy medication is being withdrawn and for six months after the last dose.

For individuals with syncope, a simple faint has no restriction on driving. A single episode that is explained and treated requires four weeks off driving. A single unexplained episode requires six months off driving, while two or more episodes require 12 months off. For individuals with other conditions such as stroke or TIA, they must take one month off driving. They may not need to inform the DVLA if there is no residual neurological deficit. If an individual has had multiple TIAs over a short period of time, they must take three months off driving and inform the DVLA. For individuals who have had a craniotomy, such as for meningioma, they must take one year off driving. If an individual has had a pituitary tumor, a craniotomy requires six months off driving, while trans-sphenoidal surgery allows driving when there is no debarring residual impairment likely to affect safe driving. Individuals with narcolepsy/cataplexy must cease driving on diagnosis but can restart once there is satisfactory control of symptoms. For individuals with chronic neurological disorders such as multiple sclerosis or motor neuron disease, they should inform the DVLA and complete the PK1 form (application for driving license holders’ state of health). If the tumor is a benign meningioma and there is no seizure history, the license can be reconsidered six months after surgery if the individual remains seizure-free.

Mirena® License for Contraception and Endometrial Hyperplasia Protection

At the moment, question stats are not available, but it is likely that many people will choose 5 years as the answer for Mirena®’s duration of use for contraception. However, it is important to note that while Mirena® is licensed for up to 5 years for contraception and idiopathic menorrhagia, it is only licensed for 4 years for protection against endometrial hyperplasia during oestrogen replacement therapy. This means that individuals using Mirena® for this purpose should have it replaced after 4 years to ensure continued protection. It is crucial to follow the recommended duration of use for Mirena® to ensure its effectiveness and safety.

Treatment and Prevention of Pertussis

Pertussis, commonly known as whooping cough, is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. Treatment with antibiotics can reduce the infectivity of the disease, but it doesn’t shorten the duration of the illness. Macrolide antibiotics are the preferred treatment for pertussis.

Immunization is the most effective way to prevent pertussis. However, the vaccine provides only 95% protection and relies on a degree of herd immunity. Infants less than 6 months old and any unwell child should be admitted to the hospital for treatment.

If left untreated, pertussis can lead to complications such as bronchiectasis and pneumonia. Therefore, it is important to seek medical attention if you suspect you or your child has pertussis. Early diagnosis and treatment can help prevent the spread of the disease and reduce the risk of complications.

Management of Bronchiolitis in Infants

Bronchiolitis is an acute infectious disease of the lower respiratory tract that commonly affects infants aged between two and six months. It is caused by respiratory syncytial virus (RSV) and peaks during the winter months. Supportive measures such as fluid input, feeding, and temperature control are the mainstay of treatment. Antibiotics are not indicated as bronchiolitis is usually caused by a virus. Hospital admission is only necessary in severe cases or if there are significant comorbidities. Salbutamol via a spacer is not indicated in bronchiolitis. Careful safety netting is important to teach parents to spot deterioration and seek medical attention if necessary. Most infants with bronchiolitis have a mild, self-limiting illness that lasts for seven to ten days.

Itraconazole and Heart Failure Risk

The use of itraconazole, a common antifungal medication, can increase the risk of heart failure in certain patients. Those most at risk include individuals with a history of heart disease, those taking calcium antagonists, and the elderly. Patients with liver disease or who are taking statins may also experience adverse effects from itraconazole. It is recommended that baseline liver function tests be performed before starting treatment. While dyspepsia, abdominal pain, nausea, and constipation are common side effects, the negative ionotropic effect of itraconazole can lead to heart failure in susceptible patients. Therefore, itraconazole should be avoided in patients with a history of heart failure unless the benefits outweigh the risks.

Urgent Referral for Unexplained Vulval Lump or Non-Responsive Ulceration

Any woman who discovers a new, unexplained lump or experiences ulceration that doesn’t respond to treatment should be referred urgently. It is important to note that the term pressure sore should be used with caution, as it may not accurately describe the condition.

If the ulcer appears to be caused by thrush, fluconazole may be considered. However, if the ulcer doesn’t arise from typical intertriginous areas and lacks satellite lesions or white discharge, a fungal infection is unlikely.

While primary syphilis can cause a solitary painless genital ulcer, it tends to resolve within four to eight weeks. Therefore, it is unlikely that this would be the first presentation of a lady with primary syphilis.

If the condition is suspected to be a pressure ulcer on the sacrum or another pressure point, a tissue viability nurse may be consulted. However, based on the given history, this seems unlikely. Referring to dermatology is not appropriate for a strongly suspected case of vulval carcinoma.

Lethargy is a common early symptom of multiple sclerosis, an autoimmune condition that affects the myelin in the brain and spinal cord. The patient’s description of symptoms of optic neuritis is also typical of multiple sclerosis. Lyme disease can sometimes mimic multiple sclerosis, but there is no history of a tick bite. Myasthenia gravis, which causes weakness and fatigue, is not likely to cause paresthesia or optic neuritis. Sarcoidosis, a systemic inflammatory disease that often presents with fatigue, is a potential option, but multiple sclerosis is more likely to cause optic neuritis.

Features of Multiple Sclerosis

Multiple sclerosis (MS) is a condition that can present with nonspecific features, such as significant lethargy in around 75% of patients. Diagnosis is based on two or more relapses and either objective clinical evidence of two or more lesions or objective clinical evidence of one lesion with reasonable historical evidence of a previous relapse.

MS can affect various parts of the body, leading to different symptoms. Visual symptoms include optic neuritis, optic atrophy, Uhthoff’s phenomenon, and internuclear ophthalmoplegia. Sensory symptoms may include pins and needles, numbness, trigeminal neuralgia, and Lhermitte’s syndrome. Motor symptoms may include spastic weakness, which is most commonly seen in the legs. Cerebellar symptoms may include ataxia and tremor. Other symptoms may include urinary incontinence, sexual dysfunction, and intellectual deterioration.

It is important to note that MS symptoms can vary greatly between individuals and may change over time. Therefore, it is crucial for patients to work closely with their healthcare providers to manage their symptoms and receive appropriate treatment.

Takayasu’s arteritis is a type of vasculitis that affects the large blood vessels, often leading to blockages in the aorta. This condition is more commonly seen in young women and Asian individuals. Symptoms may include malaise, headaches, unequal blood pressure in the arms, carotid bruits, absent or weak peripheral pulses, and claudication in the limbs during physical activity. Aortic regurgitation may also occur in around 20% of cases. Renal artery stenosis is a common association with this condition. To diagnose Takayasu’s arteritis, vascular imaging of the arterial tree is necessary, which can be done through magnetic resonance angiography or CT angiography. Treatment typically involves the use of steroids.

The individual is experiencing sudden sensorineural hearing loss, which is typically of unknown cause. It is recommended that all patients begin treatment promptly with high dose steroids (60mg/day) for seven days, as this has been shown to improve outcomes. An ENT evaluation should be scheduled immediately to conduct pure tone audiometry testing and to rule out the presence of an acoustic neuroma through an MRI. In cases where oral steroids are ineffective, intra-tympanic steroids may be administered. Aciclovir is not typically prescribed as there is no evidence to support its efficacy.

Rinne’s and Weber’s Test for Differentiating Conductive and Sensorineural Deafness

Rinne’s and Weber’s tests are used to differentiate between conductive and sensorineural deafness. Rinne’s test involves placing a tuning fork over the mastoid process until the sound is no longer heard, then repositioning it just over the external acoustic meatus. A positive test indicates that air conduction (AC) is better than bone conduction (BC), while a negative test indicates that BC is better than AC, suggesting conductive deafness.

Weber’s test involves placing a tuning fork in the middle of the forehead equidistant from the patient’s ears and asking the patient which side is loudest. In unilateral sensorineural deafness, sound is localized to the unaffected side, while in unilateral conductive deafness, sound is localized to the affected side.

The table below summarizes the interpretation of Rinne and Weber tests. A normal result indicates that AC is greater than BC bilaterally and the sound is midline. Conductive hearing loss is indicated by BC being greater than AC in the affected ear and AC being greater than BC in the unaffected ear, with the sound lateralizing to the affected ear. Sensorineural hearing loss is indicated by AC being greater than BC bilaterally, with the sound lateralizing to the unaffected ear.

Overall, Rinne’s and Weber’s tests are useful tools for differentiating between conductive and sensorineural deafness, allowing for appropriate management and treatment.

If the strawberry naevus on this baby is not causing any mechanical issues or bleeding, treatment is typically unnecessary.

Strawberry naevi, also known as capillary haemangiomas, are not usually present at birth but can develop quickly within the first month of life. They appear as raised, red, and lobed tumours that commonly occur on the face, scalp, and back. These growths tend to increase in size until around 6-9 months before gradually disappearing over the next few years. However, in rare cases, they can obstruct the airway if they occur in the upper respiratory tract. Capillary haemangiomas are more common in white infants, particularly in females, premature infants, and those whose mothers have undergone chorionic villous sampling.

Complications of strawberry naevi include obstruction of vision or airway, bleeding, ulceration, and thrombocytopaenia. Treatment may be necessary if there is visual field obstruction, and propranolol is now the preferred choice over systemic steroids. Topical beta-blockers such as timolol may also be used. Cavernous haemangioma is a type of deep capillary haemangioma.

If the patient removes her IUD on day 1-5 of her menstrual cycle and switches to the combined oral contraceptive pill (COCP), she doesn’t need any additional contraception. The COCP is effective immediately if started on these days. However, if she starts the COCP from day 6 onwards, she will need to use barrier contraception for 7 days. There is no need to delay starting the COCP after IUD removal unless there is another reason. If the patient had recently taken ulipristal as an emergency contraceptive, she would need to wait for 5 days before starting hormonal contraception, but this is not the case for this patient.

New intrauterine contraceptive devices include the Jaydess® IUS and Kyleena® IUS. The Jaydess® IUS is licensed for 3 years and has a smaller frame, narrower inserter tube, and less levonorgestrel than the Mirena® coil. The Kyleena® IUS has 19.5mg LNG, is smaller than the Mirena®, and is licensed for 5 years. Both result in lower serum levels of LNG, but the rate of amenorrhoea is less with Kyleena® compared to Mirena®.

Common Pediatric Respiratory Issues and Diagnostic Considerations

Abnormal cry and stridor are indicative of potential laryngeal issues in children. When assessing for asthma, it is important to note that it is predominantly extrinsic in nature. During acute asthma episodes, relying on peak expiratory flow rate (PEFR) may be unreliable due to poor technique. It is important to consider alternative diagnoses when a child presents with failure to thrive and clubbing, as these symptoms may suggest underlying health issues beyond respiratory concerns. By keeping these diagnostic considerations in mind, healthcare providers can more effectively identify and treat common pediatric respiratory issues.

Exenatide and its Metabolic Effects

Exenatide is a medication that imitates the effects of GLP-1, a hormone produced in the gut. It has been found to have beneficial effects on the metabolism of individuals with diabetes mellitus. This medication has several metabolic effects, including the suppression of appetite, inhibition of glucose production in the liver, slowing of gastric emptying, and stimulation of insulin release. However, it doesn’t increase insulin sensitivity, which is achieved by other drugs such as metformin and the glitazones. Overall, exenatide has been shown to have a positive impact on the management of diabetes by regulating various metabolic processes.

Managing Depression During Pregnancy: Considerations for Antidepressant Use

Depression affects up to 20% of pregnant women and can have negative impacts on both maternal and fetal health. While concerns about potential harm to the developing fetus may lead some women to discontinue antidepressant medication, doing so can increase the risk of relapse for those with a history of recurrent depression. Additionally, depressed women may engage in behaviors that contribute to poorer obstetric and neonatal outcomes.

Decisions about treating depression during pregnancy should be made on an individual basis, taking into account the severity of depression, past history of affective disorder, and maternal preference. While there are no antidepressants licensed for use during pregnancy, selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed. While the risks are thought to be low, some severe birth defects have been reported. Tricyclics are considered safer, but carry a greater risk of overdose.

In cases where a woman wishes to discontinue antidepressant medication, a gradual reduction in dose is recommended. Alternative treatments, such as psychological therapy, may also be considered. St. John’s wort should be avoided due to insufficient data on its safety in pregnancy. Ultimately, the decision to continue or discontinue antidepressant medication during pregnancy should be made in consultation with a healthcare provider.

To properly manage a patient with type 2 diabetes mellitus (T2DM) who has a history of angina, it is important to start with metformin and titrate upwards as tolerated. Additionally, an SGLT-2 inhibitor should be added regardless of glycaemic control, as it is indicated for organ protection. Once metformin tolerability is confirmed, the SGLT-2 inhibitor can be added. Starting with an SGLT-2 inhibitor first or starting both medications immediately and titrating metformin upwards as tolerated is incorrect. Adding a DPP 4 inhibitor, pioglitazone, or sulfonylurea only if adequate glycaemic control is not achieved is also not the recommended approach for this patient.

NICE has updated its guidance on the management of type 2 diabetes mellitus (T2DM) in 2022 to reflect advances in drug therapy and improved evidence regarding newer therapies such as SGLT-2 inhibitors. For the average patient taking metformin for T2DM, lifestyle changes and titrating up metformin to aim for a HbA1c of 48 mmol/mol (6.5%) is recommended. A second drug should only be added if the HbA1c rises to 58 mmol/mol (7.5%). Dietary advice includes encouraging high fiber, low glycemic index sources of carbohydrates, controlling intake of saturated fats and trans fatty acids, and initial target weight loss of 5-10% in overweight individuals.

Individual HbA1c targets should be agreed upon with patients to encourage motivation, and HbA1c should be checked every 3-6 months until stable, then 6 monthly. Targets should be relaxed on a case-by-case basis, with particular consideration for older or frail adults with type 2 diabetes. Metformin remains the first-line drug of choice, and SGLT-2 inhibitors should be given in addition to metformin if the patient has a high risk of developing cardiovascular disease (CVD), established CVD, or chronic heart failure. If metformin is contraindicated, SGLT-2 monotherapy or a DPP-4 inhibitor, pioglitazone, or sulfonylurea may be used.

Further drug therapy options depend on individual clinical circumstances and patient preference. Dual therapy options include adding a DPP-4 inhibitor, pioglitazone, sulfonylurea, or SGLT-2 inhibitor (if NICE criteria are met). If a patient doesn’t achieve control on dual therapy, triple therapy options include adding a sulfonylurea or GLP-1 mimetic. GLP-1 mimetics should only be added to insulin under specialist care. Blood pressure targets are the same as for patients without type 2 diabetes, and ACE inhibitors or ARBs are first-line for hypertension. Antiplatelets should not be offered unless a patient has existing cardiovascular disease, and only patients with a 10-year cardiovascular risk > 10% should be offered a statin.

It is recommended to try eliminating egg as the symptoms indicate a non-IgE-mediated food allergy.

Food allergies in children and young people can be categorized as either IgE-mediated or non-IgE-mediated. It is important to note that food intolerance is not caused by immune system dysfunction and is not covered by the 2011 NICE guidelines. Symptoms of IgE-mediated allergies include skin reactions such as pruritus, erythema, urticaria, and angioedema, as well as gastrointestinal and respiratory symptoms. Non-IgE-mediated allergies may present with symptoms such as gastro-oesophageal reflux disease, loose or frequent stools, and abdominal pain. If the history suggests an IgE-mediated allergy, skin prick tests or blood tests for specific IgE antibodies to suspected foods and co-allergens should be offered. If the history suggests a non-IgE-mediated allergy, the suspected allergen should be eliminated for 2-6 weeks and then reintroduced, with consultation from a dietitian for nutritional adequacies, timings, and follow-up.

Chondrodermatitis Nodularis Chronica Helicis: A Benign Tender Lump in the Ear Cartilage

Chondrodermatitis nodularis chronica helicis is a common condition characterized by a benign tender lump in the cartilaginous portion of the ear, specifically in the helix or antihelix. It is often caused by pressure between the head and pillow during sleep, particularly in individuals who predominantly sleep on one side. Minor trauma, exposure to cold, and tight headgear or telephone headsets can also trigger the condition.

The lesion rarely resolves on its own and conservative measures such as using a soft pillow or sleeping on the opposite side may be attempted. Wearing a protective pressure-relieving device, using topical and intralesional steroids, or applying topical glyceryl trinitrate may also provide relief. Cryotherapy is sometimes used as well.

Excision of the damaged cartilage area is often successful, but recurrence can occur at the edge of the excised area. The distinctive feature of chondrodermatitis nodularis chronica helicis is the associated pain and tenderness, which sets it apart from painless cutaneous tumors and non-tender actinic keratoses.

It is important to note that tophi, which contain a white pasty material and are usually not painful or tender, typically develop around 10 years after the first attack of gout in untreated patients and are commonly found around the elbows, hands, and feet.

Korsakoff’s Psychosis and Cocktail Party Speech

Korsakoff’s psychosis is a condition that can cause difficulty in memorizing new events. It is often associated with alcoholism, but it can also result from head injury, cerebral hypoxia, tumor, or encephalitis. One of the characteristic symptoms of Korsakoff’s psychosis is retrograde amnesia, which is the loss of memory for events before the onset of the illness.

On the other hand, cocktail party speech is a phenomenon that can be observed in some children with congenital syndromes that have learning difficulties. These children can engage in small talk on various topics, but they struggle when faced with more complex communication tasks.

Methotrexate and Liver Toxicity: Importance of Regular Blood Monitoring

In this case, the patient is taking methotrexate for rheumatoid arthritis and has presented with knee pain. However, the finding of raised liver function tests, although unrelated to the knee pain, should not be ignored due to the potential for methotrexate-induced liver toxicity. Regular blood monitoring is essential for patients taking methotrexate, with full blood count and renal and liver function tests performed before starting treatment and repeated weekly until therapy is stabilised. After stabilisation, bloods should be monitored at least every two to three months.

Local protocols often advise monthly blood tests on stabilised regimens, with GPs responsible for acting on any abnormal results. In this case, the patient’s ALT and ALP levels are raised to three times the upper limit of normal, indicating the need to withhold methotrexate and seek urgent advice from the local rheumatological department.

It is important to ask about over-the-counter medication use, as non-steroidal anti-inflammatory drugs (NSAIDs) can reduce methotrexate excretion and increase the risk of toxicity. Patients should be advised to avoid self-medication with aspirin and ibuprofen, and close monitoring is required if prescribed concurrently with methotrexate. Rheumatology departments often have specialist nurses available for urgent advice on managing methotrexate-induced liver toxicity.

Understanding Symptoms in Palliative Care: Indicators of End-of-Life

As a patient approaches the end of their life, it can be difficult to determine the exact moment of passing. However, certain symptoms may indicate that the end is near. Cheyne-Stokes breathing, characterized by cycles of increasingly deep and shallow respiration with possible periods of apnea, is a poor prognostic sign often seen in palliative care. Rectal bleeding may indicate progression of colorectal carcinoma, but doesn’t necessarily indicate the end of life. Abdominal distension may be related to the cancer or constipation caused by pain medication, but is not an indicator of prognosis. Grand mal seizures may require further investigation or treatment, but do not necessarily give an idea of prognosis. Pain management should be regularly reviewed, but the amount of pain doesn’t necessarily correlate with entering the end-of-life phase. Understanding these symptoms can help healthcare providers provide appropriate care and support for patients and their families during this difficult time.